Drug Guide
Acrivastine; Pseudoephedrine Hydrochloride
Classification
Therapeutic: Allergy and Cold Relief
Pharmacological: Histamine H1 Antagonist and Sympathomimetic
FDA Approved Indications
- Relief of nasal congestion, sneezing, and runny nose due to allergies or cold
Mechanism of Action
Acrivastine, an H1 antihistamine, blocks histamine receptors to reduce allergy symptoms; Pseudoephedrine is a decongestant that stimulates adrenergic receptors in nasal mucosa, causing vasoconstriction and decreasing swelling.
Dosage and Administration
Adult: Typically, 8 mg of acrivastine with 60 mg of pseudoephedrine every 4-6 hours as needed, not exceeding 4 doses in 24 hours.
Pediatric: Consult specific product guidelines; generally not recommended for children under 12 without physician oversight.
Geriatric: Adjust dosage as per clinical response; increased caution due to potential cardiovascular effects.
Renal Impairment: Use with caution; dose adjustment may be necessary.
Hepatic Impairment: Use with caution; monitor for reduced clearance.
Pharmacokinetics
Absorption: Well absorbed orally.
Distribution: Widely distributed; peak levels in 1-2 hours.
Metabolism: Metabolized in the liver (pseudoephedrine minimally metabolized).
Excretion: Excreted primarily in urine.
Half Life: Acrivastine approximately 20-24 hours; pseudoephedrine approximately 4-6 hours.
Contraindications
- Allergy to any component of the drug.
- Use of monoamine oxidase inhibitors (MAOIs) within the past 14 days.
Precautions
- History of hypertension, heart disease, or glaucoma.
- Use caution in elderly and patients with urinary retention or thyroid disease.
Adverse Reactions - Common
- Drowsiness, dry mouth, dizziness (Common)
- Nervousness, insomnia (Less common)
Adverse Reactions - Serious
- Hypertension, tachycardia, arrhythmias (Rare)
- Allergic reactions including rash, urticaria (Rare)
Drug-Drug Interactions
- Monoamine oxidase inhibitors (MAOIs), other sympathomimetics, CNS depressants
Drug-Food Interactions
N/ADrug-Herb Interactions
N/ANursing Implications
Assessment: Monitor for adverse reactions such as hypertension, nervousness, or sedation.
Diagnoses:
- Ineffective airway clearance related to nasal congestion.
- Risk for hypertension due to pseudoephedrine.
Implementation: Administer with food to minimize gastrointestinal upset. Monitor cardiovascular status.
Evaluation: Assess relief of nasal congestion and allergy symptoms.
Patient/Family Teaching
- Take medication exactly as prescribed.
- Avoid operating heavy machinery until response is known.
- Be aware of possible side effects such as dizziness or nervousness.
- Tell your doctor if you experience palpitations or hypertension.
Special Considerations
Black Box Warnings:
- Pseudoephedrine can increase blood pressure and cause cardiovascular events, caution in hypertensive patients.
Genetic Factors: Precautions in patients with genetic predispositions to drug sensitivities.
Lab Test Interference: May interfere with certain urinary assays.
Overdose Management
Signs/Symptoms: Severe hypertension, tachycardia, agitation, seizures.
Treatment: Supportive care; control blood pressure; activated charcoal if recent ingestion; consider dialysis in severe cases.
Storage and Handling
Storage: Store at room temperature away from light and moisture.
Stability: Stable for 2-3 years when unopened.